1) Wang Z, Wang C, Wei T, Mi Y, Zhou S, Liu X, Jia J, Li L, Zhao G, Tang Y. Impaired temporal coding associated with central auditory dysfunction and cognitive impairment in Alzheimer's disease. Sci Bull (Beijing). 2024 Oct 16:S2095-9273(24)00751-5. doi: 10.1016/j.scib.2024.10.012. Epub ahead of print. PMID: 39477786.

2) Yang K, Yang X, Yin P, Zhou M, Tang Y. Temporal trend and attributable risk factors of Alzheimer's disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021. Alzheimers Dement. 2024 Sep 23. doi: 10.1002/alz.14254. Epub ahead of print. PMID: 39312279.

3) Tang Y, Xing Y, Sun L, Wang Z, Wang C, Yang K, Zhu W, Shi X, Xie B, Yin Y, Mi Y, Wei T, Tong R, Qiao Y, Yan S, Wei P, Yang Y, Shan Y, Zhang X, Jia J, Teipel SJ, Howard R, Lu J, Li C, Zhao G. TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trial. Alzheimers Res Ther. 2024 Sep 12;16(1):203. doi: 10.1186/s13195-024-01570-0.

4) Zhou S, Xu J, Liu X, Li A, Zhao B, Geng C, Wei T, Liu Y, Wang Z, Tang Y. Brain fog assessment in patients recovered from COVID-19 in China: a development and validation study. Int J Neurosci. 2024 Sep 2:1-11. doi: 10.1080/00207454.2024.2398616.

5) Liu L, Wang H, Xing Y, Zhang Z, Zhang Q, Dong M, Ma Z, Cai L, Wang X, Tang Y. Dose-response relationship between computerized cognitive training and cognitive improvement. NPJ Digit Med. 2024 Aug 15;7(1):214. doi: 10.1038/s41746-024-01210-9.

6) Wang X, Su L, Han J, Han Y, Yin Y, Huang J, Tang Y, Zhao Y, Qin Q. Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations in conjunction with systemic lupus erythematosus: Missed diagnosis or misdiagnosis? Immun Inflamm Dis. 2024 Aug;12(8):e1367. doi: 10.1002/iid3.1367.

7) Lu Y, Mao F, Yin P, Chang J, Zhao Z, Yang K, Qin Q, Zhou M, Tang Y. A comprehensive index to evaluate cognitive health at the population scale. Chin Med J (Engl). Published online August 9, 2024. doi:10.1097/CM9.0000000000003241

8) Geng C, Tang Y. Association between levels of sex hormones and risk of multiple sclerosis: a mendelian randomization study. Acta Neurol Belg. Published online July 29, 2024. doi:10.1007/s13760-024-02613-x

9) Chang J, Liu Y, Zhao Y, Gao P, Tang Y. Association of sleep duration with excess risk of dementia among shift workers in the UK biobank: a population-based cohort study. J Neurol. Published online July 20, 2024. doi:10.1007/s00415-024-12580-1

10) Yin Y, Yang H, Li R, Wu G, Qin Q, Tang Y. What do the conflicting findings in the trem2 transgenetic mouse model tell us? A systematic review of the role of TREM2 in Alzheimer's disease. Chin Med J (Engl). Published online June 24, 2024. doi:10.1097/CM9.0000000000003000

11) Li QG, Xing Y, Zhu ZD, Fei XL, Tang Y, Lu J. Effects of computerized cognitive training on functional brain networks in patients with vascular cognitive impairment and no dementia. CNS Neurosci Ther. 2024;30(6):e14779. doi:10.1111/cns.14779

12) Liu Y, Chang J, Zhao Y, Tang Y. Neuroticism personality, social contact, and dementia risk: A prospective cohort study. J Affect Disord. 2024;358:391-398. doi:10.1016/j.jad.2024.05.055

13) Geng C, Meng K, Tang Y. Identifying the mediating role of inflammation on the relationship between socioeconomic status and Alzheimer's disease: a Mendelian randomization analysis and mediation analysis. J Neurol. 2024;271(5):2484-2493. doi:10.1007/s00415-023-12176-1

14) Geng C, Meng K, Zhao B, Liu X, Tang Y. Causal relationships between type 1 diabetes mellitus and Alzheimer's disease and Parkinson's disease: a bidirectional two-sample Mendelian randomization study. Eur J Med Res. 2024;29(1):53. doi:10.1186/s40001-023-01628-z

15) Geng C, Wang Z, Tang Y. Machine learning in Alzheimer's disease drug discovery and target identification. Ageing Res Rev. 2023 Dec 15:102172. doi: 10.1016/j.arr.2023.102172.

16) Wang M, Wei T, Yu C, Li R, Yin Y, Yang H, Di R, Xia X, Qin Q, Tang Y. Integrative Metabolomics and Whole Transcriptome Sequencing Reveal Role for TREM2 in Metabolism Homeostasis in Alzheimer's Disease. Mol Neurobiol. 2023 Dec 8. doi: 10.1007/s12035-023-03840-8.

17) Li J, Shan Y, Zhao X, Shan G, Wei PH, Liu L, Wang C, Wu H, Song W, Tang Y, Zhao GG, Lu J. Structural and functional changes in the brain after chronic complete thoracic spinal cord injury. Brain Res. 2024 Jan 15;1823:148680. doi: 10.1016/j.brainres.2023.148680.

18) Zhao K, Chen P, Alexander-Bloch A, Wei Y, Dyrba M, Yang F, Kang X, Wang D, Fan D, Ye S, Tang Y, Yao H, Zhou B, Lu J, Yu C, Wang P, Liao Z, Chen Y, Huang L, Zhang X, Han Y, Li S, Liu Y. A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study. EClinicalMedicine. 2023 Oct 26;65:102276. doi: 10.1016/j.eclinm.2023.102276.

19) Liu Y, Wang Z, Wei T, Zhou S, Yin Y, Mi Y, Liu X, Tang Y. Alterations of Audiovisual Integration in Alzheimer's Disease. Neurosci Bull. 2023 Dec;39(12):1859-1872. doi: 10.1007/s12264-023-01125-7.

20) Liu LY, Xing Y, Zhang ZH, Zhang QG, Dong M, Wang H, Cai L, Wang X, Tang Y. Validation of a Computerized Cognitive Training Tool to Assess Cognitive Impairment and Enable Differentiation Between Mild Cognitive Impairment and Dementia. J Alzheimers Dis. 2023;96(1):93-101. doi: 10.3233/JAD-230416.

21) Wei T, Shi X, Sun W, Song W, Zhou S, Zhao Y, Wang Z, Tang Y. Identifying Suitable Targets for Alzheimer's Disease and Other Eight Common Neurological Disorders Using the Human Plasma Proteome: A Mendelian Randomization Study. J Alzheimers Dis Rep. 2023 Aug 4;7(1):811-822. doi: 10.3233/ADR-230058.

22) Nie Y, Chu C, Qin Q, Shen H, Wen L, Tang Y, Qu M. Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment. Brain Pathol. 2024 Jan;34(1):e13202. doi: 10.1111/bpa.13202.

23) Zhou S, Wei T, Liu X, Liu Y, Song W, Que X, Xing Y, Wang Z, Tang Y. Causal effects of COVID-19 on structural changes in specific brain regions: a Mendelian randomization study. BMC Med. 2023 Jul 19;21(1):261. doi: 10.1186/s12916-023-02952-1.

24) Yang H, Qin Q, Wang M, Yin Y, Li R, Tang Y. Crosstalk between peripheral immunity and central nervous system in Alzheimer's disease. Cell Immunol. 2023 Sep-Oct;391-392:104743. doi: 10.1016/j.cellimm.2023.104743.

25) Teipel S, Tang Y, Boccardi M. Predicting cognitive decline in older people by structural and molecular imaging. Curr Opin Neurol. 2023 Aug 1;36(4):253-263. doi: 10.1097/WCO.0000000000001172.

26) Liu XD, Wei T, Shi L, Zhou SJ, Liu YF, Song WY, Que XW, Wang ZB, Tang Y. Causal relationship between gastroesophageal reflux disease, Barrett's esophagus, and epilepsy: A bidirectional Mendelian randomization study. Brain Behav. 2023 Sep;13(9):e3117. doi: 10.1002/brb3.3117.

27) Qin Q, Qu J, Yin YS, Liang Y, Wang Y, Xie BJ, Liu Q, Wang X, Xia X, Wang M, Zhang X, Jia JP, Xing Y, Li CL, Tang Y. Unsupervised machine learning model to predict cognitive impairment in subcortical ischemic vascular disease. Alzheimers Dement. 2023 Aug;19(8):3327-3338. doi: 10.1002/alz.12971

28) Qin Q, Wang M, Li H, Xu ZD, Tang Y. Editorial: The role of microglia in the pathogenesis of neurodegenerative diseases. Front Aging Neurosci. 2023 Jan 6:14:1105896. doi: 10.3389/fnagi.2022.1105896.

29) Liu PP, Dai SK, Mi TW, Tang GB, Wang Z, Wang H, Du HZ, Tang Y, Teng ZQ, Liu CM. Acetate supplementation restores cognitive deficits caused by ARID1A haploinsufficiency in excitatory neurons. EMBO Mol Med. 2022 Nov 17:e15795. doi: 10.15252/emmm.202215795.

30) Yu CJ, Wang M, Li RY, Wei T, Yang HC, Yin YS, Mi YX, Qin Q, Tang Y. TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology. Mol Neurobiol. 2023 Feb;60(2):512-523. doi: 10.1007/s12035-022-03100-1.

31) Xia X, Qin Q, Peng Y, Wang M, Yin Y, Tang Y. Retinal Examinations Provides Early Warning of Alzheimer's Disease. J Alzheimers Dis. 2022;90(4):1341-1357. doi: 10.3233/JAD-220596.

32) Shi X, Wei T, Hu Y, Wang M, Tang Y. The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study. J Neuroinflammation. 2022 Sep 6;19(1):218.

33) Lutz MW, Khachaturian AS, Zetterberg H, Blennow K, Willette AA, Mielke MM, Hayden KM, Dodge HH, Tang Y, Greenberg BD, Kukull WA, Khachaturian ZS. Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide. Alzheimers Dement. 2022 Sep;18(9):1595-1601.

34) Zhang SF, Dai SK, Du HZ, Wang H, Li XG, Tang Y, Liu CM. The epigenetic state of EED-Gli3-Gli1 regulatory axis controls embryonic cortical neurogenesis. Stem Cell Reports. 2022 Sep 13;17(9):2064-2080.

35) Yu Y, Lu Y, Wang F, Lu Y, Xie B, Meng X, Tang Y. Acanthocytes Identified in Huntington's Disease. Front Neurosci. 2022 Jun 6; 16:913401. doi: 10.3389/fnins.2022.913401.

36) Qin Q, Wang M, Yin Y, Tang Y. The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer's Disease. Front Immunol. 2022 May 19; 13:845897. doi: 10.3389/fimmu.2022.845897.

37) Wang YY, Deng YS, Dai SK, Mi TW, Li RY, Liu PP, Liu C, HeBD, He XC, Du HZ, Yang HC, Tang Y, Liu CM, Teng ZQ. Loss of microglial EED impairs synapse density, learning and memory. Mol Psychiatry. 2022 Jul; 27(7):2999-3009. doi: 10.1038/s41380-022-01576-w.

38) Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS, Wang M, Yu CJ, Tang Y. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener. 2022 Jun 3;17(1):40. doi: 10.1186/s13024-022-00542-y.

39) Wei T, Guo Z, Wang Z, Li C, Zhu W, Zheng Y, Yin Y, Mi Y, Xia X, Hou H, Tang Y. Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study. J Alzheimers Dis. 2022 Mar 31. doi: 10.3233/JAD-220010.

40) Mi Y, Qin Q, Xing Y, Tang Y. Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer's Disease. J Alzheimers Dis. 2022 Mar 2. doi: 10.3233/JAD-215565.

41) Temp AGM, Ly A, van Doorn J, Wagenmakers EJ, Tang Y, Lutz MW, Teipel S. A Bayesian perspective on Biogen's aducanumab trial. Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12615.

42) Shenoy SA, Zheng S, Liu W, Dai Y, Liu Y, Hou Z, Mori S, Tang Y, Cheng J, Duan W, Li C. A novel and accurate full-length HTT mouse model for Huntington's disease. Elife. 2022 Jan 13;11:e70217. doi: 10.7554/eLife.70217.

43) Teipel S, Gustafson D, Ossenkoppele R, Hansson O, Babiloni C, Wagner M, Riedel-Heller S, Kilimann I, Tang Y. Alzheimer's disease - standard of diagnosis, treatment, care, and prevention. J Nucl Med. 2022 Feb 10:jnumed.121.262239. doi: 10.2967/jnumed.121.262239.

44) Qin Q, Yin Y, Xing Y, Wang X, Wang Y, Wang F, Tang Y. Lipid Metabolism in the Development and Progression of Vascular Cognitive Impairment: A Systematic Review. Front Neurol. 2021 Nov 19;12:709134. doi: 10.3389/fneur.2021.709134.

45) Xing Y, Yang J, Zhou A, Wang F, Tang Y, Jia J. Altered brain activity mediates the relationship between white matter hyperintensity severity and cognition in older adults. Brain Imaging Behav. 2022 Apr;16(2):899-908. doi: 10.1007/s11682-021-00564-y.

46) Wang C, Wang Z, Xie B, Shi X, Yang P, Liu L, Qu T, Qin Q, Xing Y, Zhu W, Teipel SJ, Jia J, Zhao G, Li L, Tang Y. Binaural processing deficit and cognitive impairment in Alzheimer’s disease. 2022 Jun;18(6):1085-1099. doi: 10.1002/alz.12464.

47) Wang Z, Zhu W, Xing Y, Jia J, Tang Y. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis. Nutr Rev. 2022 Mar 10;80(4):931-949.

Temp AGM, Lutz MW, Trepel D, Tang Y, Wagenmakers EJ, Khachaturian AS, Teipel S. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease. Alzheimers Dement. 2021 Jun;17(6):917-919. doi: 10.1002/alz.12374.

48) Xing Y, Yang J, Zhou A, Wang F, Wei C, Tang Y, Jia J. White Matter Fractional Anisotropy Is a Superior Predictor for Cognitive Impairment Than Brain Volumes in Older Adults With Confluent White Matter Hyperintensities. Front Psychiatry. 2021 May 5;12:633811. doi: 10.3389/fpsyt.2021.633811. eCollection 2021.

49) Wang F, Ma X, Shi Y, Jia L, Zuo X, Yu Y, Jin H, Tang Y, Guo D, Jia J. Cognitive profiles in adult-onset neuronal intranuclear inclusion disease: a case series from the memory clinic. Neurol Sci. 2020; doi: 10.1007/s10072-020-04864-x.

50) Wang Z, Yang J, Zhu W, Tang Y, Jia J. The synaptic marker neurogranin as a disease state biomarker in Alzheimer's disease: a systematic review and meta-analysis. Int J Neurosci. 2021; 10:1-9. doi: 10.1080/00207454.2021.1881087.

51) Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Y. TREM2, microglia, and Alzheimer's disease. Mech Ageing Dev. 2021 Apr;195:111438. doi: 10.1016/j.mad.2021.111438.

52) Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, Song Y, Shi Y, Zhang H, Gong M, Wei C, Tang Y, Fang B, Guo D, Wang F, Zhou A, Chu C, Zuo X, Yu Y, Yuan Q, Wang W, Li F, Shi S, Yang H, Zhou C, Liao Z, Lv Y, Li Y, Kan M, Zhao H, Wang S, Yang S, Li H, Liu Z, Wang Q, Qin W, Jia J; COAST Group. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661-e671.

53) Jia L, Li F, Wei C, Zhu M, Qu Q, Qin W, Tang Y, Shen L, Wang Y, Shen L, Li H, Peng D, Tan L, Luo B, Guo Q, Tang M, Du Y, Zhang J, Zhang J, Lyu J, Li Y, Zhou A, Wang F, Chu C, Song H, Wu L, Zuo X, Han Y, Liang J, Wang Q, Jin H, Wang W, Lü Y, Li F, Zhou Y, Zhang W, Liao Z, Qiu Q, Li Y, Kong C, Li Y, Jiao H, Lu J, Jia J. Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study. Brain. 2020. doi: 10.1093/brain/awaa364.

54) Sikkes SAM, Tang Y, Jutten RJ, Wesselman LMP, Turkstra LS, Brodaty H, Clare L, Cassidy-Eagle E, Cox KL, Chételat G, Dautricourt S, Dhana K, Dodge H, Dröes RM, Hampstead BM, Holland T, Lampit A, Laver K, Lutz A, Lautenschlager NT, McCurry SM, Meiland FJM, Morris MC, Mueller KD, Peters R, Ridel G, Spector A, van der Steen JT, Tamplin J, Thompson Z; ISTAART Non-pharmacological Interventions Professional Interest Area, Bahar-Fuchs A. Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations. Alzheimers Dement. 2020 Nov 20. doi: 10.1002/alz.12188.

55) Jia L, Xu H, Chen S, Wang X, Yang J, Gong M, Wei C, Tang Y, Qu Q, Chu L, Shen L, Zhou C, Wang Q, Zhao T, Zhou A, Li Y, Li F, Li Y, Jin H, Qin Q, Jiao H, Li Y, Zhang H, Lyu D, Shi Y, Song Y, Jia J. The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease. Alzheimers Dement. 2020. doi: 10.1002/alz.12153.

56) Jia L, Xu H, Chen S, Wang X, Yang J, Gong M, Wei C, Tang Y, Qu Q, Chu L, Shen L, Zhou C, Wang Q, Zhao T, Zhou A, Li Y, Li F, Li Y, Jin H, Qin Q, Jiao H, Li Y, Zhang H, Lyu D, Shi Y, Song Y, Jia J. The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease. Alzheimers Dement. 2020. doi: 10.1002/alz.12153.

57) Tang Y, Xing Y, Cui L, Wu C, Wen X, Song H, Wu L, Chang H, Song J, Wang Y, Zhao G. Neurology practice during the COVID-19 outbreak and post-pandemic era: experiences and challenges. Eur J Neurol. 2020 Jul 17:10.1111/ene.14445. doi: 10.1111/ene.14445.

58) Jia L, Zhu M, Kong C, Pang Y, Zhang H, Qiu Q, Wei C, Tang Y, Wang Q, Li Y, Li T, Li F, Wang Q, Li Y, Wei Y, Jia J. Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage. Alzheimers Dement. 2020 Aug 10. doi: 10.1002/alz.12166.

59) Qin Q, Yin Y, Wang Y, Lu Y, Tang Y, Jia J. Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status. Mol Genet Genomic Med. 2020 Aug 6:e1443. doi: 10.1002/mgg3.1443.

60) New Thinking About Thinking, Part 3. Advice on Preparing a Successful Manuscript for Alzheimer's & Dementia. Alzheimers Dement. 2020 Jun 24.  doi: 10.1002/alz.12141. Online ahead of print. PMID: 32578941. DOI: 10.1002/alz.12141

61) Xing Y, Zhu Z, Du Y, Zhang J, Qu Q, Sun L, Li Y, Guo Y, Peng G, Liu Y, Yu Y, Qiao Y, Xie B, Shi X, Lu J, Jia J, Tang Y. The Efficacy of COGnitive tRaining in patiEnts with Amnestic mild coGnitive impairmENT (COG-REAGENT): Protocol for a Multi-Center Randomized Controlled Trial. J Alzheimers Dis. 2020;75(3):779-787.

62) Xing Y, Wei P, Wang C, Shan Y, Yu Y, Qiao Y, Xie B, Shi X, Zhu Z, Lu J, Zhao G, Jia J, Tang Y. TRanscranial AlterNating current Stimulation FOR patients with Mild Alzheimer's Disease (TRANSFORM-AD study): Protocol for a randomized controlled clinical trial. Alzheimers Dement (N Y). 2020;6(1):e12005.

63) Xie B, Shi X, Xing Y, Tang Y. Association between atherosclerosis and Alzheimer's disease: A systematic review and meta-analysis. Brain Behav. 2020;10(4):e01601.

64) Qin Q, Tang Y, Dou X, Qu Y, Xing Y, Yang J, Chu T, Liu Y, Jia J. Default mode network integrity changes contribute to cognitive deficits in subcortical vascular cognitive impairment, no dementia. Brain Imaging Behav. 2020. doi: 10.1007/s11682-019-00252-y.

65) Jia J, Wei C, Chen W, Jia L, Zhou A, Wang F, Tang Y, Xu L. Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease. J Alzheimers Dis. 2020. doi: 10.3233/JAD-190940.

66) Jia L, Fu Y, Shen L, Zhang H, Zhu M, Qiu Q, Wang Q, Yan X, Kong C, Hao J, Wei C, Tang Y, Qin W, Li Y, Wang F, Guo D, Zhou A, Zuo X, Yu Y, Li D, Zhao L, Jin H, Jia J. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease. Alzheimers Dement. 2020;16(1):178-191.

67) Tang Y, Liu Y, Li D, Guo D, Xing Y. A novel mutation in the CYP27A1 gene in a family with cerebrotendinous xanthomatosis. Int J Neurosci. 2020; 1-4.

68) Quan M, Zhao T, Tang Y, Luo P, Wang W, Qin Q, Li T, Wang Q, Fang J, Jia J. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease. Alzheimers Res Ther. 2020;12(1):14.

69) Wang H, Fan Z, Shi C, Xiong L, Zhang H, Li T, Sun Y, Guo Q, Tian Y, Qu Q, Zhang N, Cheng Z, Wu L, Wu D, Han Z, Tian J, Xie H, Tan S, Gao J, Luo B, Pan X, Peng G, Qin B, Tang Y, Wang K, Wang T, Zhang J, Zhao Q, Gauthier S, Yu X. Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project. Journal of global health. 2019; 9(2): 020320

70) Shi X, Xie B, Xing Y, Tang Y. Plasma Clusterin as a Potential Biomarker for Alzheimer's Disease-A Systematic Review and Meta-analysis. Curr Alzheimer Res. 2019;16(11):1018-1027.

71) Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, Tang Y, Qin Q, Wang F, Qiao Y, Shi S, Wang YJ, Du Y, Zhang J, Zhang J, Luo B, Qu Q, Zhou C, Gauthier S, Jia J; Group for the Project of Dementia Situation in China. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020 Jan;19(1):81-92.

72) Shen L, Qin W, Wu L, Zhou A, Tang Y, Wang Q, Jia L, Jia J. Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer's pedigrees and their functional characterization. Biochem Biophys Res Commun. 2019;516(1):264-269.

73) Tang Y, Xing Y, Zhu Z, He Y, Li F, Yang J, Liu Q, Li F, Teipel SJ, Zhao G, Jia J. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): A randomized controlled trial. Alzheimers Dement. 2019;15(5):605-614.

74) Liu Z, Jiao L, Qiu Z, Da Y, Tang Y, Lin Y, Li D, Huang J, Kang X, Dong H. Clinical characteristics of patients with paraneoplastic myelopathy.  J Neuroimmunol. 2019 ;330:136-142.

75) Tang Y, Qin Q, Xing Y, Guo D, Di L, Jia J. AARS2 leukoencephalopathy: a new variant of mitochondrial encephalomyopathy. Mol Genet Genomic Med. 2019; 7(4):e00582.

76) Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, Dreux S, Edland S, Esbensen A, Evered L, Ewers M, Fargo KN, Fortea J, Gonzalez H, Gustafson DR, Head E, Hendrix JA, Hofer SM, Johnson LA, Jutten R, Kilborn K, Lanctôt KL, Manly JJ, Martins RN, Mielke MM, Morris MC, Murray ME, Oh ES, Parra MA, Rissman RA, Roe CM, Santos OA, Scarmeas N, Schneider LS, Schupf N, Sikkes S, Snyder HM, Sohrabi HR, Stern Y, Strydom A, Tang Y, Terrera GM, Teunissen C, Melo van Lent D, Weinborn M, Wesselman L, Wilcock DM, Zetterberg H, O'Bryant SE; International Society to Advance Alzheimer's Research and Treatment, Alzheimer's Association. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimers Dement. 2019;15(2):292-312.

77) Du X, Ji Y, Chen T, Tang Y, Han B. Can working memory capacity be expanded by boosting working memory updating efficiency in older adults? Psychology and Aging. 2018;33(8):1134-1151. (IF 2.608)

78) Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Shi L, Gong M, Xu H, Li F, He J, Song H, Yang S, Zhou A, Wang F, Zuo X, Chu C, Liang J, Jia L, Gauthier S. Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial. Alzheimers Dement (N Y): TRCI. 2018; 4:108-117.

79) Tang Y, Lutz MW, Xing Y. A systems-based model of Alzheimer's disease. Alzheimers Dement. 2019;15(1):168-171.

80) Hayden KM, Inouye SK, Cunningham C, Jones RN, Avidan MS, Davis D, Kuchel GA, Tang Y, Khachaturian AS. Reduce the burden of dementia now. Alzheimers Dement. 2018;14(7):845-847.

81) Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS. New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia. Alzheimers Dement. 2018;14(6):703-706.

82) Li J, Wu L, Tang Y, Zhou A, Wang F, Xing Y, Jia J. Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer's disease. BMC Neurol. 2018;18(1):65.

83) Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, Kukull WA, Mohs R, Khachaturian ZS. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimers Dement. 2018;14(4):532-534.

84) Wang Z, Qin W, Wei CB, Tang Y, Zhao LN, Jin HM, Li Y, Wang Q, Luan XQ, He JC, Jia J. The microRNA-1908 up-regulation in the peripheral blood cells impairs amyloid clearance by targeting ApoE. Int J Geriatr Psychiatry. 2018;33(7):980-986.

85) Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, Zhao L, Jin H, Xu H, Wang F, Zhou A, Zuo X, Wu L, Han Y, Han Y, Huang L, Wang Q, Li D, Chu C, Shi L, Gong M, Du Y, Zhang J, Zhang J, Zhou C, Lv J, Lv Y, Xie H, Ji Y, Li F, Yu E, Luo B, Wang Y, Yang S, Qu Q, Guo Q, Liang F, Zhang J, Tan L, Shen L, Zhang K, Zhang J, Peng D, Tang M, Lv P, Fang B, Chu L, Jia L, Gauthier S. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483-491

86) Zhang Y, Guo D, Tang Y. Autonomic dysfunction in a patient with X-linked adrenoleukodystrophy. Int J Neurosci.  2017; 28:1-2

87) Liu Q, Zhu Z, Teipel SJ, Yang J, Xing Y, Tang Y, Jia J White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia. Front. Aging Neurosci. 2017; 9: 47.

88) Jia J, Gauthier S, Pallotta S, Ji Y, Wei W, Xiao S, Peng D, Guo Q, Wu L, Chen S, Kuang W, Zhang J, Wei C, Tang Y. Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease. Alzheimers Dement. 2017;13(5):592-597.

89) Dong J, Qin W, Wei C, Tang Y, Wang Q, Jia J. A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.  J Alzheimers Dis. 2017;57(2):613-623.

90) Jia J, Wei C, Jia L, Tang Y, Liang J, Zhou A, Li F, Shi L, Doody RS. Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial. J Alzheimers Dis. 2017;56(4):1495-1504.

91) Xing Y, Tang Y, Zhao L, Wang Q, Qin W, Ji X, Zhang J, Jia J. Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia. J Neurol Sci. 2016;370:82-87.

92) Tang Y, Zhu Z, Liu Q, Li F, Yang J, Li F, Xing Y, Jia J. The efficacy of Cognitive training in patients with VAsCular Cognitive Impairment, No dEmentia (the Cog-VACCINE study): study protocol for a randomized controlled trial. Trials. 2016;17(1):392.

93) Xing Y, Tang Y, Zhao L, Wang Q, Qin W, Zhang J, Jia J. Plasma ceramides and neuropsychiatric symptoms of Alzheimer’s disease. J Alzheimers Dis. 2016; 52(3):1029-35.

94) Jia J, Zuo X, Jia XF, Chu C, Wu L, Zhou A, Wei C, Tang Y, Li D, Qin W, Song H, Ma Q, Li J, Sun Y, Min B, Xue S, Xu E, Yuan Q, Wang M, Huang X, Fan C, Liu J, Ren Y, Jia Q, Wang Q, Jiao L, Xing Y, Wu X; China Cognition and Aging Study (COAST) Group. Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. Alzheimers Dement. 2016; 12(4):446-53.

95) Xing Y, Tang Y, Jia J. Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status. Behav Neurol. 2015;2015:275256. doi: 10.1155/2015/275256.

96) Tang Y, Wang X, Jia J. Mercury poisoning presenting as sporadic creutzfeldt-jakob disease: a case report. Ann Intern Med. 2015;162(6):462-3.

97) Lu H, Wang XB, Tang Y. Subdural hematoma associated with high altitude. Chin Med J (Engl). 2015;128(3):407-8.

98) Qin W, Jia X, Wang F, Zuo X, Wu L, Zhou A, Li D, Min B, Wei C, Tang Y, Xing Y, Dong X, Wang Q, Gao Y, Li Y, Jia J. Elevated plasma angiogenesis factors in Alzheimer's disease. J Alzheimers Dis. 2015;45(1):245-52.

99) Liang J, Li F, Wei C, Song H, Wu L, Tang Y, Jia J. Rationale and Design of a Multicenter, Phase 2 Clinical Trial to Investigate the Efficacy of Traditional Chinese Medicine SaiLuoTong in Vascular Dementia. J Stroke Cerebrovasc Dis. 2014; 23(10):2626-34.

100) Jia J, Zhou A, Wei C, Jia X, Wang F, Li F, Wu X, Mok V, Gauthier S, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439-47.

101) Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. 2014;10(1):1-9

102) Jia J, Wang F, Yuan Q, Qin W, Tang Y, Zuo XM, Han Y. Progresses on Genetics of Predementia Phase of Alzheimer's Disease. Prog Biochem Biophys. 2012;39(8), 698-702.

103) Xing Y, Wei C, Chu C, Zhou A, Li F, Wu L, Song H, Zuo X, Wang F, Qin W, Li D, Tang Y, Jia XF, Jia J. Stage-specific gender differences in cognitive and neuropsychiatric manifestations of vascular dementia. Am J Alzheimers Dis Other Demen. 2012;27(6):433-8.

104) Tang Y, Xing Y, Lin MT, Zhang J, Jia J. Hashimoto's encephalopathy cases: Chinese experience. BMC Neurol. 2012; 24;12:60.

105) Dong HQ, Liu Z, Tang Y, Lu Y, Wang Q, Jia J. Recurrent Fisher-Bickerstaff syndrome: report of a Chinese case. Chin Med J (Engl). 2011;124(17):2786-8.

106) Tang Y, Chu C, Lin MT, Wei G, Zhang X, Da Y, Huang H, Jia J. Hashimoto's encephalopathy mimicking spinocerebellar ataxia. J Neurol. 2011;258(9):1705-7.

107) Huang H, Chen J, Lin T, Wang T, Tang Y, Dong Y, Wang J. Epoxyeicosatrienoic acids--novel mechanism and pharmacological therapy of chronic renocardiac syndrome. Med Hypotheses. 2011;76(4):550-2.

108) Tang Y, Ding Y, Li CJ, Wang XB, Jia J. longitudinal lesion of the spinal cord in a patient with Vogt-Koyanagi-Harada disease. J Neurol Neurosurg Psychiatry 2010;81:941-942

109) Xu EH, Tang Y, Li D, Jia J. Polymorphism of HD and UCHL-1 genes in Huntington's disease. J Clin Neurosci. 2009, 16(11):1473-7.

110) Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V, Zhou C, Geghman K, Bogdanov M, Przedborski S, Beal MF, Burke RE, Li C. Mutant hR1441G LRRK2 BAC Transgenic Mice Recapitulate Cardinal Features of Parkinson’s Disease. Nature Neuroscience 2009, 12(7):826-8.

111) Tang Y, Huang Y, Shen W, Liu DP, Liu G, Wang Z, Tang XB, Liang CC. Cluster specific regulation pattern of upstream regulatory elements in human α- and β-globin gene clusters. Exp. Cell Res. 2008, 314(1):115-22

112) Wei YJ, Tang Y, Cui CJ, Zhang H, Liu XN, Zhang H, Hu SS. Expression pattern of dog stromal cell derived factor-1 (SDF-1) and implications in ischemic myocardium. Cytokine 2007, 40(1):52-9

113) Tang XB, Feng DX, Di LJ, Huang Y, Fu XH, Liu G, Tang Y, Liu DP, Liang CC. HS-48 alone has no enhancement role on the expression of human alpha-globin gene cluster. Blood Cells Mol Dis. 2007, 38(1):32-6

114) Tang Y, Wang Z, Huang Y, Liu G, Shen W, Tang XB, Feng DX, Liu DP, Liang CC, Gene Order in Human alpha-globin Locus is Required for Their Temporal Specific Expressions. Genes Cells. 2006,11(2):123-31.

115) Shen W, Huang Y, Tang Y, Liu DP, Liang CC. A General Method to Modify BACs to Generate Large Recombinant DNA Fragments Mol. Biotechnology.2005, 31: 181-186

116) Huang Y, Liu DP, Feng DX, Wu M, Shen W, Tang Y, Tang XB, Liang CC. No existence of translocus balancer to coordinate the expression and regulation of human hemoglobin genes in transgenic mice study. Int J Biochem Cell Biol. 2004, 36(7): 1261-5.

117) Tang Y, Liu DP, Liang CC. Further understanding of the beta-globin locus regulation at the molecular level: looping or linking models? Genes Cells. 2002, 7(9): 889-900.